Weekly Wrap Up – September 9, 2022 Bivalent Booster Dose RecommendationsReminder: The bivalent booster recommendations replace all prior booster recommendations for individuals 12 years and older. Monovalent mRNA vaccines are no longer authorized as a booster dose for people ages 12 years and
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Weekly Wrap Up – September 9, 2022

Bivalent Booster Dose Recommendations


Reminder: The bivalent booster recommendations replace all prior booster recommendations for individuals 12 years and older.

  • Monovalent mRNA vaccines are no longer authorized as a booster dose for people ages 12 years and older and should not be administered as such for this age group
  • Children ages 5–11 years are recommended to continue receiving 1 monovalent mRNA booster dose if eligible
  • Only monovalent vaccines are approved or authorized for primary series doses
  • J&J vaccine remains available as first booster for certain people.

Please see below for a visual aid of bivalent booster dose eligibility:



Please see CDC Interim Clinical Considerations: Appendix D for guidance on incorrectly administering a bivalent booster dose. All vaccine administration errors should be reported to VAERS.


Additional Resources:

  • COVID-19 Vaccine Timing Guide | Spanish
  • CDC Interim Clinical Considerations for COVID-19 Vaccines
  • Interim Clinical Considerations for COVID-19 Vaccines: Bivalent Booster Doses

 

Bivalent Booster Dose Storage & Handling

Cap colors, label colors, and outdated language can be easily confused. Continue to carefully check vial labels to ensure that the intended product is administered. See below for Pfizer and Moderna labels that may cause confusion.

Pfizer Labels


Moderna Labels



For more information, please see Preventing Vaccine Administration Errors and COVID-19 Vaccine Product Guide.


 


myCAvax Release 30


Release 30 will go live September 15, 2022. Please stay tuned for additional details. 


The myCAvax team is always looking for feedback on how to better improve the myCAvax experience. If you have feedback or suggestions for future improvements, please complete the survey here. 


 


15-Minute Post-Vaccination Observation Period Update


The 15-minute post-vaccination observation period is now optional. COVID-19 vaccine Providers, particularly when vaccinating adolescents, should consider observing vaccine recipients for 15 minutes. For further information, including considerations for 30-minute observation periods, please see CDC Interim Clinical Considerations for Use of COVID-19 Vaccines.

 

 


Provider FAQ of the Week


Q:  How long after COVID-19 illness can people receive COVID-19 vaccination?

A:  People with known current SARS-CoV-2 infection should defer any COVID-19 vaccination, including booster vaccination, at least until recovery from the acute illness (if symptoms were present) and criteria to discontinue isolation have been met.  People who recently had SARS-CoV-2 infection may consider delaying a primary series dose or booster dose by 3 months from symptom onset or positive test (if infection was asymptomatic). For further information, please see CDC Interim Clinical Considerations for Use of COVID-19 Vaccines.

Full list of Provider FAQs, updated weekly

 

Pfizer COVID-19 Vaccine Medical Updates & Training Sessions

Session Topics Include:

  • Authorization of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) for individuals 12 years of age and older 
  • Use of each currently authorized vaccine presentation, including storage, handling, preparation, and administration
  • Question and answer session

Please attend one of the following training sessions:

  • Monday, September 12 at 12PM
  • Tuesday, September 13 at 12PM 
  • Wednesday, September 14 at 9AM 
  • Thursday, September 15 at 9AM 
  • Friday, September 16 at 12PM

To access all sessions, please visit Pfizer COVID-19 Medical Updates and Training.


 

Useful Resources

  • COVID-19 Provider Operations Manual
  • Talking with Patients about Bivalent Booster Doses Slides | Recording
  • Ordering & Distribution Cadence Calendar
  • Vaccine Administration Checklist
  • CMA COVID-19 Vaccine Reimbursement Guide
  • Recommending COVID-19 Vaccination: Clinical Talking Points for Providers of Pediatric Services
  • Coadministration Tips

 


Support Opportunities


Provider Office Hours


Please attend our weekly webinars to hear updates from the COVID-19 Vaccination Program and have your questions answered.

  • Fridays 9–10 AM
  • Archived Sessions | Provider FAQs

COVID-19 Therapeutics Webinar for LHDs and Providers

  • Biweekly Mondays 12–1PM | Next session: Monday, September 12

My Turn & myCAvax Office Hours for LHDs and Providers

  • Biweekly Mondays 12–1PM | Next session: Monday, September 19

COVID Call Center for Providers

  • For Program information: email covidcallcenter@cdph.ca.gov or call (833) 502-1245 (Monday – Friday, 8AM–6PM)

myCAvax Help Desk

  • For technical issues (password resets, etc.): email myCAvax.HD@accenture.com or call (833) 502-1245, option 3 (Monday – Friday 8AM – 6PM)
  • System related training materials are available via the Knowledge Center in myCAvax and at EZIZ.org/COVID

My Turn Help Desk

  • Onboarding: email myturnonboarding@cdph.ca.gov Technical support for My Turn Clinic: email MyTurn.Clinic.HD@Accenture.com or call (833) 502-1245, option 4 (Monday – Friday 8AM – 6PM).
  • Job aids, demos and training opportunities

 

View Archived Messages

‌COVID19 Vaccination Program

‌‌California Dept of Public | Immunization Branch
850 Marina Bay Pkwy
Richmond CA 94804
View In Browser

Copyright @Microsoft Dynamics, All right reserved.

850 Marina Bay Parkway, Bldg P Richmond CA 94804

Unsubscribe